An interventional study of CapExchange in Mental Disorder and Psychosocial Rehabilitation, sponsored by EPSM de la Guadeloupe. Not yet recruiting at 1 site in Guadeloupe. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-29.
Sponsored by EPSM de la Guadeloupe · Not applicable, Interventional, and Health services research
CapExchange is a psychosocial rehabilitation programme based on reciprocal exchange of capacities and services between service users and their community environment, grounded in the concepts of circular mutuality and micro-social contribution. This pilot feasibility study aims to assess the feasibility and acceptability of the programme within the Psychosocial Rehabilitation Service of the EPSM de la Guadeloupe, across three sites: the Unité Passerelle, the CATTG Doubs, and the UREPS outpatient unit. A sample of 10 to 15 adult service users with a stabilized mental disorder is targeted. The intervention comprises five weekly group sessions of 75 minutes. Primary measures include the Social Contribution Score (SCS) and the Warwick-Edinburgh Mental Well-being Scale (WEMWBS).
1,740 studies on the registry are indexed under Mental Disorders; 348 are open to participants now.
This study's planned enrollment of 15 is below the median of 100 across 1,301 interventional studies indexed under Mental Disorders.
Browse Mental Disorders studies →This is the only study on the registry with EPSM de la Guadeloupe as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Five weekly group sessions of 75 minutes based on reciprocal exchange of capacities and services between service users and their community environment.
Behavioral: CapExchange
A structured group programme comprising five weekly sessions of 75 minutes based on reciprocal exchange of capacities and services between service users and their community environment, grounded in the concepts of circular mutuality and micro-social contribution.
Recruitment rate
Proportion of eligible service users agreeing to participate in the programme
Time frame: 3 months
Plan to share: No — Individual participant data will not be shared given the pilot and feasibility nature of this study and the small sample size.
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for Sep 2027, 8 months later.
Of 666 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 8 months is below that.
Counting every sponsor, half of 680 studies reached it within 29 months; a quarter within 13 and three quarters within 45.
Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.